|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 253.7 BDT | +0.28% |
|
+0.04% | -11.48% |
The IBN SINA Pharmaceutical Industry PLC reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was BDT 8,479.82 million compared to BDT 7,376.04 million a year ago. Net income was BDT 605.87 million compared to BDT 489.12 million a year ago.
Basic earnings per share from continuing operations was BDT 19.39 compared to BDT 15.66 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.48% | 72.19M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
THE IBN SINA PHARMACEUTICAL INDUSTRY PLC 
